Elena García Arias-Salgado, PhD

Senior researcher
La Paz University Hospital

PhD in Biochemistry and Molecular Biology by the Universidad Complutense de Madrid in 2001. I have developed my research career in prestigious institutes of the Spanish National Research Council (CSIC), in American research centers as The Scripps Research Institute (TSRI) and the University of California San Diego (UCSD), and the biomedical company AMP. Currently, I am a senior researcher in the group of Coagulopathies in the Institute for Health Research of Hospital Universitario La Paz (IdiPAZ), Madrid, Spain. My scientific interest has been focused on the characterization of the genetic and molecular basis of the hemostasis and coagulation, with special emphasis on signaling pathways implicated in the platelet physiology and pathological processes of hemostatic rare disorders.

Presentation(s):

• PB0536 - Ex vivo study of the concomitant use of plasma-derived Factor VIII/Von Willebrand Factor and emicizumab in patients with severe Hemophilia A

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1054 - Evaluation of platelet function in rare or undiagnosed bleeding disorders

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1172 - Impact of inhibitors on the procoagulant efficacy of bypass agents or hemostatic factors in combination with emicizumab

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1206 - Effect of agonists to thrombopoietin receptors on platelet glycome of patients with immune thrombocytopenia

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1208 - Discontinuation of thrombopoietin receptor agonists: a 10 year real-world experience from an academic hospital in Madrid

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1238 - Effect of constitutive activation of the calcium sensor STIM1 on haemostasis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM